Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials

Affiliations

• ¹ Medical Department A, University Hospital Münster, Münster, Germany. [email protected].
• ² Centre Henri-Becquerel and University of Rouen, Rouen, France.
• ³ Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
• ⁴ University of Montpellier, Montpellier, France.
• ⁵ Medical Department A, University Hospital Münster, Münster, Germany.
• ⁶ Onkologie Lerchenfeld, Hamburg, Germany.
• ⁷ Genentech Inc., South San Francisco, CA, USA.
• ⁸ F. Hoffmann-La Roche Ltd, Basel, Switzerland.
• ⁹ Hoffmann-La Roche Ltd, Mississauga, ON, Canada.
• ¹⁰ University of Lille, Centre Hospitalier Universitaire, Lille, France.